73 related articles for article (PubMed ID: 9874508)
1. Mechanism involved in gallium-67 (Ga-67) uptake by human lymphoid cell lines.
Nejmeddine F; Caillat-Vigneron N; Escaig F; Moretti JL; Raphael M; Galle P
Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1215-20. PubMed ID: 9874508
[TBL] [Abstract][Full Text] [Related]
2. Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.
Ul-Haq R; Chitambar CR
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):873-7. PubMed ID: 8379943
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of gallium-67 uptake in melanoma by an anti-human transferrin receptor monoclonal antibody.
Chan SM; Hoffer PB; Maric N; Duray P
J Nucl Med; 1987 Aug; 28(8):1303-7. PubMed ID: 3475407
[TBL] [Abstract][Full Text] [Related]
4. Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells.
Weiner RE; Avis I; Neumann RD; Mulshine JL
J Cell Biochem Suppl; 1996; 24():276-87. PubMed ID: 8806110
[TBL] [Abstract][Full Text] [Related]
5. Transferrin receptor-dependent and -independent iron transport in gallium-resistant human lymphoid leukemic cells.
Chitambar CR; Wereley JP
Blood; 1998 Jun; 91(12):4686-93. PubMed ID: 9616166
[TBL] [Abstract][Full Text] [Related]
6. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
[TBL] [Abstract][Full Text] [Related]
7. 67Ga scintigraphy in B-cell non-Hodgkin's lymphoma: correlation of 67Ga uptake with histology and transferrin receptor expression.
Nejmeddine F; Raphael M; Martin A; Le Roux G; Moretti JL; Caillat-Vigneron N
J Nucl Med; 1999 Jan; 40(1):40-5. PubMed ID: 9935054
[TBL] [Abstract][Full Text] [Related]
8. Effect of modulation of the transferrin receptor on gallium-67 uptake and cytotoxicity in lymphoma cell lines.
van Leeuwen-Stok AE; Schuurhuis GJ; Dräger AM; Visser-Platier AW; Teule GJ; Huijgens PC
Br J Cancer; 1996 Aug; 74(4):619-24. PubMed ID: 8761380
[TBL] [Abstract][Full Text] [Related]
9. Uptake of 111In-labeled fully human monoclonal antibody TSP-A18 reflects transferrin receptor expression in normal organs and tissues of mice.
Sugyo A; Tsuji AB; Sudo H; Nomura F; Satoh H; Koizumi M; Kurosawa G; Kurosawa Y; Saga T
Oncol Rep; 2017 Mar; 37(3):1529-1536. PubMed ID: 28184946
[TBL] [Abstract][Full Text] [Related]
10. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
Recht LD; Griffin TW; Raso V; Salimi AR
Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
[TBL] [Abstract][Full Text] [Related]
11. Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin-independent mechanisms.
Chitambar CR; Zivkovic Z
Cancer Res; 1987 Aug; 47(15):3929-34. PubMed ID: 3475168
[TBL] [Abstract][Full Text] [Related]
12. Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate.
Chitambar CR; Purpi DP; Woodliff J; Yang M; Wereley JP
J Pharmacol Exp Ther; 2007 Sep; 322(3):1228-36. PubMed ID: 17600139
[TBL] [Abstract][Full Text] [Related]
13. Modulation of lymphocyte proliferation and immunoglobulin production by transferrin-gallium.
Chitambar CR; Seigneuret MC; Matthaeus WG; Lum LG
Cancer Res; 1989 Mar; 49(5):1125-9. PubMed ID: 2537143
[TBL] [Abstract][Full Text] [Related]
14. Disparity between expression of transferrin receptor ligand binding and non-ligand binding domains on human lymphocytes.
Boldt DH; Phillips JL; Alcantara O
J Cell Physiol; 1987 Aug; 132(2):331-6. PubMed ID: 3624319
[TBL] [Abstract][Full Text] [Related]
15. Uptake of gallium-67 in transfected cells and tumors absent or enriched in the transferrin receptor.
Luttropp CA; Jackson JA; Jones BJ; Sohn MH; Lynch RE; Morton KA
J Nucl Med; 1998 Aug; 39(8):1405-11. PubMed ID: 9708518
[TBL] [Abstract][Full Text] [Related]
16. Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: identification of novel intermediates.
Davies NP; Suryo Rahmanto Y; Chitambar CR; Richardson DR
J Pharmacol Exp Ther; 2006 Apr; 317(1):153-62. PubMed ID: 16373528
[TBL] [Abstract][Full Text] [Related]
17. Differential growth-inhibitory effects of gallium on B-lymphocyte lines in high versus low iron concentrations.
Kovar J; Seligman P; Gelfand EW
Cancer Res; 1990 Sep; 50(18):5727-30. PubMed ID: 2393846
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.
Chitambar CR; Boon P; Wereley JP
Clin Cancer Res; 1996 Jun; 2(6):1009-15. PubMed ID: 9816262
[TBL] [Abstract][Full Text] [Related]
19. Gallium-pyridoxal isonicotinoyl hydrazone (Ga-PIH), a novel cytotoxic gallium complex. A comparative study with gallium nitrate.
Knorr GM; Chitambar CR
Anticancer Res; 1998; 18(3A):1733-7. PubMed ID: 9673397
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumours in vivo.
Panaccio M; Zalcberg JR; Thompson CH; Leyden MJ; Sullivan JR; Lichtenstein M; McKenzie IF
Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():461-72. PubMed ID: 2452131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
